80 related articles for article (PubMed ID: 32213734)
41. Prevalence and incidence of fatty liver for people who took part in a health checkup in 2008-2019 in Japan.
Chen S; Liaw YP
Liver Int; 2022 Jun; 42(6):1479. PubMed ID: 35474602
[No Abstract] [Full Text] [Related]
42. Authors' response to "prevalence and incidence of fatty liver for people who took part in a health checkup in 2008-2019 in Japan".
Sugiyama A; Kurisu A; Akita T; Tanaka J
Liver Int; 2022 Jun; 42(6):1478. PubMed ID: 35312148
[No Abstract] [Full Text] [Related]
43. Corrigendum: Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients.
Chen H; Dai S; Fang Y; Chen L; Jiang K; Wei Q; Ding K
Front Oncol; 2021; 11():742987. PubMed ID: 34490128
[TBL] [Abstract][Full Text] [Related]
44. The effect of different treatment strategies on glycolipid metabolism disorders and cardiovascular events in primary aldosteronism.
Zhou S; Liu J; Li Z; Yang M; Sha R; Yan R; Wang X; Cao Y
Hypertens Res; 2024 Jun; 47(6):1719-1727. PubMed ID: 38565699
[TBL] [Abstract][Full Text] [Related]
45. Meta-analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism.
Zhu QG; Zhu F
J Clin Hypertens (Greenwich); 2023 Jan; 25(1):13-21. PubMed ID: 36484331
[TBL] [Abstract][Full Text] [Related]
46. Pathophysiology of NASH in endocrine diseases.
Gariani K; Jornayvaz FR
Endocr Connect; 2021 Feb; 10(2):R52-R65. PubMed ID: 33449917
[TBL] [Abstract][Full Text] [Related]
47. Mineralocorticoid receptors in the pathogenesis of insulin resistance and related disorders: from basic studies to clinical disease.
Jia G; Lockette W; Sowers JR
Am J Physiol Regul Integr Comp Physiol; 2021 Mar; 320(3):R276-R286. PubMed ID: 33438511
[TBL] [Abstract][Full Text] [Related]
48. [Primary aldosteronism].
Fardella CE; Mosso LM; Carvajal CA
Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
[TBL] [Abstract][Full Text] [Related]
49. Primary aldosteronism - treatment options.
Young WF
Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
[TBL] [Abstract][Full Text] [Related]
50. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
[TBL] [Abstract][Full Text] [Related]
51. Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism.
Shibayama Y; Wada N; Baba S; Miyano Y; Obara S; Iwasaki R; Nakajima H; Sakai H; Usubuchi H; Terae S; Nakamura A; Atsumi T
J Endocr Soc; 2018 Nov; 2(11):1236-1245. PubMed ID: 30374468
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
[TBL] [Abstract][Full Text] [Related]
53. Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
Ohno Y; Sone M; Inagaki N; Yamasaki T; Ogawa O; Takeda Y; Kurihara I; Umakoshi H; Ichijo T; Katabami T; Wada N; Ogawa Y; Yoshimoto T; Kawashima J; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Miyauchi S; Kamemura K; Fukuoka T; Yamamoto K; Otsuki M; Suzuki T; Naruse M;
J Clin Endocrinol Metab; 2018 Dec; 103(12):4456-4464. PubMed ID: 30165444
[TBL] [Abstract][Full Text] [Related]
54. Superficial vs Deep Subcutaneous Adipose Tissue: Sex-Specific Associations With Hepatic Steatosis and Metabolic Traits.
Brand T; van den Munckhof ICL; van der Graaf M; Schraa K; Dekker HM; Joosten LAB; Netea MG; Riksen NP; de Graaf J; Rutten JHW
J Clin Endocrinol Metab; 2021 Sep; 106(10):e3881-e3889. PubMed ID: 34137897
[TBL] [Abstract][Full Text] [Related]
55. The risk factors for hepatic steatosis in patients with primary aldosteronism.
Shibayama Y; Wada N; Baba S; Obara S; Sakai H; Usubuchi H; Terae S; Nakamura A; Atsumi T
Endocr J; 2020 Jun; 67(6):623-629. PubMed ID: 32213734
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
